Skip to main content

Fiscal Wizard · Single-issue tearsheet

SYK / Jun 21, 2026 Run #7535

SYK

Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Composite verdict

D 36.6 / 100
Bearish setup · Reversal 7 drivers · 5 gates blocking
  • Chaikin Money Flow
  • MA Rejection
  • Accumulation/Distribution Line
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 36th of 141 in Medical Devices

rescore-sweep
Technical synthesisRegime: volatile range
Bull 0%Evidence: High · 15 signals100% Bear
Momentum Bearish 16Mean-reversion Neutral 43

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -74%
Asset value $58.48Earnings power value $73.60Price $307.80

Priced above its no-growth earnings power value ($73.60/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Above average

64.9 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Revenue Growth (YoY) 100
OCF to Net Income 0
Payout Ratio 97
Earnings Yield 0

Technicals Bearish

8.3 / 100

Bearish setup leads (Chaikin Money Flow, MA Rejection, Williams %R); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Chaikin Money Flow 19
MA Rejection 23
Accumulation/Distribution Line 28

Risk Gates

5 blocking 1 caution

5 guards active, 24 signals gated.

Beneish M-Score Blocking

Bottom-band Beneish M blocks bullish signals — accounting-quality risk.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for SYK.